Research Library
EARLY TRANSLATIONAL

Melanotan II

Also known as: MT-2, MT-II

Neuropeptide ResearchPeptide Signaling
ClassificationSynthetic cyclic analog of alpha-melanocyte-stimulating hormone (α-MSH).
TargetsMelanocortin receptor family; Melanogenesis signaling models

Molecular Overview

Melanotan II is a cyclic α-MSH analog studied for non-selective melanocortin-receptor activation in laboratory models.

Mechanistic Background

Broad agonism across melanocortin receptor subtypes in experimental systems.

What Researchers Study

Early clinical investigation in the 1990s-2000s; ongoing receptor-pharmacology research.

Evidence Landscape

Current evidence level: EARLY TRANSLATIONAL. Preclinical evidence does not equate to demonstrated human efficacy.

Research Limitations

Never approved; known safety signals in the literature; strictly laboratory use.

Documentation

Research Use Only

Molecularix Biolabs provides research materials for legitimate laboratory research. Information in this Research Library is provided for educational and scientific reference purposes and is not medical advice, treatment guidance, or a recommendation for human or veterinary use.